Rosko, Ashley E.
Elsaid, Mohamed I.
Woyach, Jennifer
Islam, Nowshin
Lepola, Noah
Urrutia, Jazmin
Christian, Lisa M.
Presley, Carolyn
Mims, Alice
Burd, Christin E.
Article History
Received: 3 October 2023
Accepted: 4 April 2024
First Online: 28 April 2024
Declarations
:
: This study was approved by The Ohio State University's Institutional Review Board and patients were consented for participation in this research.
: A. M. has served on the scientific advisory board of Abbvie, Genentech, BMS, Rigel Pharmaceuticals, Ryvu Therapeutics and has served on the data and safety monitoring board of Jazz Pharmaceuticals, Daiichi Saynko, and Foghorn Therapeutics. She also serves as a Senior Medical Director for the Leukemia and Lymphoma Society’s Beat AML study.